Pediatric Atopic Dermatitis (AD) Internet Survey

• Status: Withdrawn
• Trial end date: 2014-10-27
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate whether participation in an Internet-based intervention helps improve atopic dermatitis treatment outcomes.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wake Forest University; Wake Forest University Health Sciences need to be deleted
• Treatments: Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• Any child age 2 to 8 with a diagnosis of atopic dermatitis confirmed by a dermatologist, together with the child's parent/guardian. Written consent must be given by parent/guardian.

Exclusion Criteria:

• Child is less than 2 or greater than 8 years of age.

• Known allergy or sensitivity to topical triamcinolone in the child.

• Inability to complete all study-related visits, or inability to complete the Internet survey due to inadequate Internet access.

• Introduction of any other prescription medication, topical or systemic, for atopic dermatitis while participating in the study. Subjects who are on systemic anti-inflammatory treatments for atopic dermatitis must be on a stable dose for at least 3 months prior to enrollment.